Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily

Blueprint Medicines (BPMC) Similar Stocks

534 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$5.66B
-26.10
76.65%
9 Buy
4 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$35.07B
-453.96
55.62%
16 Buy
6 Hold
0 Sell
Moderate Buy
Crispr Therapeutics AG
$4.22B
-15.36
4.58%
10 Buy
6 Hold
2 Sell
Moderate Buy
Kura Oncology
$1.55B
-9.09
110.38%
9 Buy
1 Hold
0 Sell
Strong Buy
FibroGen
$42.17M
-0.25
-46.90%
0 Buy
0 Hold
1 Sell
Moderate Sell

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
BPMC
Blueprint Medicines
90.94
40.37
79.83%
ALNY
Alnylam Pharma
276.33
100.81
57.44%
CRSP
Crispr Therapeutics AG
49.49
2.93
6.29%
KURA
Kura Oncology
21.08
12.08
134.22%
FGEN
FibroGen
0.42
-0.45
-51.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis